Archive

Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures

– TissueCypher® Barrett’s Esophagus Assay is First Precision Medicine Platform for Prevention of Esophageal Cancer –   PITTSBURGH, Penn., March 21 2018 — Cernostics, a privately-held company focused on delivering next-generation cance... Read more
Customer Service

Mon-Fri 9am-5pm (EST)

×